Scholars Central

ArticlePublished 2010

Leczenie molekularnie ukierunkowane chorych na zlośliwe glejaki mózgu

Authors: Janusz Rolski, Bogdan Gliński, Pawel Blecharz, Agnieszka Chrostowska

Onkologia i Radioterapia

Volume 4 · Issue 3 · Pages 32–37

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Malignant gliomas are the most common primary brain tumours in adult patients. Despite modest improvement in survival, the prognosis is still far from expected in this disease. Molecularly directed (targeted) therapies investigated to date include inhibitors of the EGFR (epidermal growth factor receptor) and anti-antiangiogenic agent VEGFR (vascular endothelial growth factor receptor). Unfortunately, the number of patients with long-term response to this agents remains low. The results of already conducted and preliminary results of ongoing clinical trials assessing the role of monoclonal antibodies against EGFR and VEGF are presented. Rationale for such forms of treatment and of different options of targeted therapy are also discussed. It seems, that identification of biomarkers that will allow a more accurate prediction of which patients are likely to benefit from a specific treatment is of particular importance.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Onkologia i Radioterapia.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalOnkologia i Radioterapia
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Janusz Rolski”
  • BylineArticles whose byline prints “Bogdan Gliński”
  • BylineArticles whose byline prints “Pawel Blecharz”
  • BylineArticles whose byline prints “Agnieszka Chrostowska”